The emerging multidrug-resistant fungus, Candida auris, has been reported in the United States, England, and a number of other countries in recent years after first reported in Japan in 2009.
Now,...
The U.S. Food and Drug Administration today approved Cresemba (isavuconazonium sulfate), a new antifungal drug product used to treat adults with invasive aspergillosis and invasive mucormycosis, rare but...
Viamet Pharmaceuticals announced Thursday that VT-1129, a potent and selective, oral, antifungal agent, has been granted orphan drug designation by the U.S. Food & Drug Administration (FDA) for the...
Privacy Overview
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.
